| Interactions between Xenobiotics and DME (XEOTIC)
|
| Fungicide(s), Herbicide(s) or Insecticide(s) |
| Fungicide |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Fenarimol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00946
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Fungicide |
| DME Modulation |
Fenarimol inhibits the drug-metabolizing activity of DME SRD5A2 |
[1] |
| Prochloraz |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00955
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Fungicide |
| DME Modulation |
Prochloraz inhibits the drug-metabolizing activity of DME SRD5A2 |
[2] |
| Health or Environmental Toxicant(s) |
| Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Cadmium |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01503
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Cadmium up-regulates the expression of DME SRD5A2 |
[3] |
| Piperidine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01432
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Piperidine inhibits the drug-metabolizing activity of DME SRD5A2 |
[4], [5] |
| Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Aflatoxin B1 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00806
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen-mycotoxin |
| DME Modulation |
Aflatoxin B1 inhibits the expression of DME SRD5A2 |
[6] |
| Environmental Pollutant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Dichlorodiphenyl dichloroethylene |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00768
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Environmental Pollutant |
| DME Modulation |
Dichlorodiphenyl dichloroethylene inhibits the drug-metabolizing activity of DME SRD5A2 |
[1] |
| Natural Product(s), Extract(s) or Medicine(s) |
| Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Osajin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01570
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Natural Product |
| DME Modulation |
Osajin inhibits the drug-metabolizing activity of DME SRD5A2 |
[7] |
| Pharmaceutical Agent(s) |
| Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 6 Xenobiotics
|
| Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cyclosporine inhibits the expression of DME SRD5A2 |
[8] |
| Dutasteride |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00192
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Dutasteride inhibits the expression of DME SRD5A2 |
[9] |
| Estradiol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00090
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Estradiol inhibits the expression of DME SRD5A2 |
[8] |
| Finasteride |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00129
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Finasteride inhibits the drug-metabolizing activity of DME SRD5A2 (IC50 < 0.0001 microM) |
[10], [11] |
| Flutamide |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00038
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Flutamide inhibits the drug-metabolizing activity of DME SRD5A2 |
[1] |
| Zoledronic acid |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00140
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Zoledronic acid up-regulates the expression of DME SRD5A2 |
[12], [13] |
| Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Epigallocatechin gallate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00613
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 3 |
| DME Modulation |
Epigallocatechin gallate inhibits the expression of DME SRD5A2 |
[14] |
| Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Chlorogenic acid |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01246
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Chlorogenic acid inhibits the expression of DME SRD5A2 |
[14] |
| Genistein |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00557
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Genistein inhibits the expression of DME SRD5A2 |
[14] |
| Other Chemical Compound(s) or Element(s) |
| Chemical Compound |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Pregnadienes |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00815
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Chemical Compound |
| DME Modulation |
Pregnadienes inhibits the expression of DME SRD5A2 |
[15] |
|
|
|
|
|
|